Lista de obras -

A potential role for PTEN in the diabetic heart

artículo científico publicado en 2006

Adenosine A(3) receptor activation protects the myocardium from reperfusion/reoxygenation injury

artículo científico publicado en 2002

Atorvastatin and myocardial reperfusion injury: new pleiotropic effect implicating multiple prosurvival signaling

artículo científico publicado en 2005

Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling.

artículo científico publicado en 2013

Chronic metformin associated cardioprotection against infarction: not just a glucose lowering phenomenon.

artículo científico publicado en 2013

Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning

artículo científico publicado en 2004

Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner.

scientific article published on 22 October 2013

Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury

artículo científico publicado en 2011

Failure of the Adipocytokine, Resistin, to Protect the Heart From Ischemia-Reperfusion Injury

artículo científico publicado en 2010

Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten?

artículo científico publicado en 2005

Glimepiride treatment facilitates ischemic preconditioning in the diabetic heart

artículo científico publicado en 2012

Glucagon like peptide-1 is protective against myocardial ischemia/reperfusion injury when given either as a preconditioning mimetic or at reperfusion in an isolated rat heart model

artículo científico publicado en 2005

Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury

artículo científico publicado en 2005

Heat shock protein 27 protects the heart against myocardial infarction

artículo científico publicado en 2004

Is this truly ischemic preconditioning?

artículo científico publicado en 2006

Ischemia-reperfusion injury and cardioprotection: investigating PTEN, the phosphatase that negatively regulates PI3K, using a congenital model of PTEN haploinsufficiency

artículo científico publicado en 2008

Ischemic preconditioning protects by activating prosurvival kinases at reperfusion

scientific article published on 09 September 2004

Leptin, the obesity-related adipocytokine, protects the myocardium against ischaemia–reperfusion injury

Letter to the editor: "Zinc and cardioprotection: the missing link".

artículo científico publicado en 2009

Loss of PINK1 increases the heart's vulnerability to ischemia-reperfusion injury.

artículo científico publicado en 2013

Metformin cardioprotects the diabetic heart by inhibiting mPTP opening via the risk pathway

Metformin prevents myocardial reperfusion injury by activating the adenosine receptor.

artículo científico publicado en 2009

Metformin protects against myocardial reperfusion injury via PI3-kinase-dependent inhibition of mitochondrial permeability transition

Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening

artículo científico publicado en 2007

Mitochondrial PINK1--a novel cardioprotective kinase?

artículo científico publicado en 2008

Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway

scientific article published on 01 August 2007

PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning

artículo científico publicado en 2002

Pioglitazone mimics preconditioning in the isolated perfused rat heart: a role for the prosurvival kinases PI3K and P42/44MAPK.

artículo científico publicado en 2005

Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway

artículo científico publicado en 2004

Preconditioning the diabetic heart: the importance of Akt phosphorylation

artículo científico publicado en 2005

Proteomic analysis of the luteal endometrial secretome

artículo científico publicado en 2009

Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion

scientific article published on 06 March 2011

Silencing PTEN, a negative regulator of the PI3K/AKT pathway, is not sufficient to confer protection against simulated ischaemia and reperfusion

The Akt1 isoform is an essential mediator of ischaemic preconditioning

artículo científico publicado en 2012

The adipocytokine, resistin, is not cardioprotective despite activating components of the risk pathway

The diabetic heart: too sweet for its own good?

artículo científico publicado en 2012

The power of drug co-administration: smaller doses better outcomes

artículo científico publicado en 2007

Transitory activation of AMPK at reperfusion protects the ischaemic-reperfused rat myocardium against infarction

artículo científico publicado en 2010

Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations

artículo científico publicado en 2010

p53 down-regulation: a new molecular mechanism involved in ischaemic preconditioning

artículo científico publicado en 2003

Lista de obras de

A potential role for PTEN in the diabetic heart

Adenosine A(3) receptor activation protects the myocardium from reperfusion/reoxygenation injury

Atorvastatin and myocardial reperfusion injury: new pleiotropic effect implicating multiple prosurvival signaling

Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling.

Chronic metformin associated cardioprotection against infarction: not just a glucose lowering phenomenon.

Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning

Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner.

Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury

Failure of the Adipocytokine, Resistin, to Protect the Heart From Ischemia-Reperfusion Injury

Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten?

Glimepiride treatment facilitates ischemic preconditioning in the diabetic heart

Glucagon like peptide-1 is protective against myocardial ischemia/reperfusion injury when given either as a preconditioning mimetic or at reperfusion in an isolated rat heart model

Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury

Heat shock protein 27 protects the heart against myocardial infarction

Is this truly ischemic preconditioning?

Ischemia-reperfusion injury and cardioprotection: investigating PTEN, the phosphatase that negatively regulates PI3K, using a congenital model of PTEN haploinsufficiency

Ischemic preconditioning protects by activating prosurvival kinases at reperfusion

Leptin, the obesity-related adipocytokine, protects the myocardium against ischaemia–reperfusion injury

Letter to the editor: "Zinc and cardioprotection: the missing link".

Loss of PINK1 increases the heart's vulnerability to ischemia-reperfusion injury.

Metformin cardioprotects the diabetic heart by inhibiting mPTP opening via the risk pathway

Metformin prevents myocardial reperfusion injury by activating the adenosine receptor.

Metformin protects against myocardial reperfusion injury via PI3-kinase-dependent inhibition of mitochondrial permeability transition

Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening

Mitochondrial PINK1--a novel cardioprotective kinase?

Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway

PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning

Pioglitazone mimics preconditioning in the isolated perfused rat heart: a role for the prosurvival kinases PI3K and P42/44MAPK.

Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway

Preconditioning the diabetic heart: the importance of Akt phosphorylation

Proteomic analysis of the luteal endometrial secretome

Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion

Silencing PTEN, a negative regulator of the PI3K/AKT pathway, is not sufficient to confer protection against simulated ischaemia and reperfusion

The Akt1 isoform is an essential mediator of ischaemic preconditioning

The adipocytokine, resistin, is not cardioprotective despite activating components of the risk pathway

The diabetic heart: too sweet for its own good?

The power of drug co-administration: smaller doses better outcomes

Transitory activation of AMPK at reperfusion protects the ischaemic-reperfused rat myocardium against infarction

Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations

p53 down-regulation: a new molecular mechanism involved in ischaemic preconditioning